Literature DB >> 7824474

[Plasmodium falciparum malaria: type R1 quinine resistance in East Africa].

S Molinier, P Imbert, D Verrot, M Morillon, D Parzy, J E Touze.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7824474

Source DB:  PubMed          Journal:  Presse Med        ISSN： 0755-4982            Impact factor:   1.228


× No keyword cloud information.
  4 in total

1.  In vitro activities of quinine and other antimalarials and pfnhe polymorphisms in Plasmodium isolates from Kenya.

Authors:  John Okombo; Steven M Kiara; Josea Rono; Leah Mwai; Lewa Pole; Eric Ohuma; Steffen Borrmann; Lynette Isabella Ochola; Alexis Nzila
Journal:  Antimicrob Agents Chemother       Date:  2010-06-01       Impact factor: 5.191

2.  Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparum.

Authors:  Véronique Parquet; Maud Henry; Nathalie Wurtz; Jerome Dormoi; Sébastien Briolant; Marine Gil; Eric Baret; Rémy Amalvict; Christophe Rogier; Bruno Pradines
Journal:  Malar J       Date:  2010-05-25       Impact factor: 2.979

3.  Plasmodium falciparum Na+/H+ exchanger 1 transporter is involved in reduced susceptibility to quinine.

Authors:  Maud Henry; Sébastien Briolant; Agnès Zettor; Stéphane Pelleau; Meili Baragatti; Eric Baret; Joel Mosnier; Rémy Amalvict; Thierry Fusai; Christophe Rogier; Bruno Pradines
Journal:  Antimicrob Agents Chemother       Date:  2009-03-09       Impact factor: 5.191

4.  In vitro activities of benflumetol against 158 Senegalese isolates of Plasmodium falciparum in comparison with those of standard antimalarial drugs.

Authors:  B Pradines; A Tall; T Fusai; A Spiegel; R Hienne; C Rogier; J F Trape; J Le Bras; D Parzy
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.